Rxivist logo

Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease

By Galen E.B. Wright, Nicholas S Caron, Bernard Ng, Lorenzo Casal, Xiaohong Xu, Jolene Ooi, Mahmoud A. Pouladi, Sara Mostafavi, Colin J.D. Ross, Michael R. Hayden

Posted 11 Jul 2019
bioRxiv DOI: 10.1101/699033

Huntington disease (HD) is a neurodegenerative disorder that is caused by a CAG repeat expansion in the HTT gene. In an attempt to identify genomic modifiers that contribute towards the age of onset of HD, we performed a transcriptome wide association study assessing heritable differences in genetically determined expression in diverse tissues, employing genome wide data from over 4,000 patients. This identified genes that showed evidence for colocalization and replication, with downstream functional validation being performed in isogenic HD stem cells and patient brains. Enrichment analyses detected associations with various biologically-relevant gene sets and striatal coexpression modules that are mediated by CAG length. Further, cortical coexpression modules that are relevant for HD onset were also associated with cognitive decline and HD-related traits in a longitudinal cohort. In summary, the combination of population-scale gene expression information with HD patient genomic data identified novel modifier genes for the disorder.

Download data

  • Downloaded 419 times
  • Download rankings, all-time:
    • Site-wide: 38,242 out of 88,628
    • In genomics: 3,597 out of 5,654
  • Year to date:
    • Site-wide: 26,193 out of 88,628
  • Since beginning of last month:
    • Site-wide: 20,620 out of 88,628

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News